Article info

Concise report
The antibody response against human and chimeric anti-TNF therapeutic antibodies primarily targets the TNF binding region
Free

Authors

  • K A van Schie Sanquin Research, Department of Immunopathology, Amsterdam, The Netherlands Landsteiner Laboratory, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • M H Hart Sanquin Research, Department of Immunopathology, Amsterdam, The Netherlands Landsteiner Laboratory, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • E R de Groot Sanquin Research, Department of Immunopathology, Amsterdam, The Netherlands Landsteiner Laboratory, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • S Kruithof Sanquin Research, Department of Immunopathology, Amsterdam, The Netherlands Landsteiner Laboratory, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • L A Aarden Sanquin Research, Department of Immunopathology, Amsterdam, The Netherlands Landsteiner Laboratory, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • G J Wolbink Sanquin Research, Department of Immunopathology, Amsterdam, The Netherlands Landsteiner Laboratory, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands Jan van Breemen Research Institute | Reade, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • T Rispens Sanquin Research, Department of Immunopathology, Amsterdam, The Netherlands Landsteiner Laboratory, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Theo Rispens, Sanquin Blood Supply, Plesmanlaan 125, Amsterdam 1066 CX, The Netherlands; T.rispens{at}sanquin.nl
View Full Text

Citation

van Schie KA, Hart MH, de Groot ER, et al
The antibody response against human and chimeric anti-TNF therapeutic antibodies primarily targets the TNF binding region

Publication history

  • Received July 8, 2014
  • Revised September 15, 2014
  • Accepted October 5, 2014
  • First published October 23, 2014.
Online issue publication 
October 31, 2019

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.